Recombinant Dictyostelium discoideum Mitochondrial substrate carrier family protein W (mcfW) |
|||
| MBS7019992-01mg | MyBiosource | 0.1mg | EUR 2600 |
Recombinant Dictyostelium discoideum Mitochondrial substrate carrier family protein W (mcfW) |
|||
| MBS7019992-5x01mg | MyBiosource | 5x0.1mg | EUR 11660 |
Recombinant Dictyostelium discoideum Mitochondrial substrate carrier family protein W (mcfW), partial |
|||
| MBS7083191-INQUIRE | MyBiosource | INQUIRE | Ask for price |
MCF7-382 |
|||
| CSC-6288W | Creative Bioarray | One Frozen vial | Ask for price |
|
Description: Breast Carcinoma Cells |
|||
MCF7 [MCF-7] Cell Line |
|||
| CL-0149 | Elabscience Biotech | 1×10⁶ cells/vial | EUR 420 |
|
Description: Homo sapiens, Human |
|||
Mcf2l/ Rat Mcf2l ELISA Kit |
|||
| ELI-39671r | Lifescience Market | 96 Tests | EUR 1063.2 |
MCF7 382 |
|||
| ABC-TC0641 | AcceGen | 1 vial | Ask for price |
|
Description: Species: human, Caucasian female 69 years old; Tissue: breast; Tumor: adenocarcinoma; Transfected with pBact, expression vector under control of the human beta actin promotor, resistant to G418S. Original line: MCF7; Derived from: pleural effusion. |
|||
MCF7 422 |
|||
| ABC-TC0642 | AcceGen | 1 vial | Ask for price |
|
Description: Species: human, Caucasian female 69 years old; Tissue: breast; Tumor: adenocarcinoma; Transfected with ER-pBact, human estrogen receptor cDNA, under control of the human beta actin promotor, resistant to G418S.; Original line: MCF7; Derived from: pleural effusion. |
|||
MCF7 432 |
|||
| ABC-TC0643 | AcceGen | 1 vial | Ask for price |
|
Description: Species: human, Caucasian female 69 years old; Tissue: breast; Tumor: adenocarcinoma; Transfected with the exon 4 defective variant of ER-pBact cDNA, human estrogen receptor cDNA, under control of the human beta actin promotor resistant to G418S.; Original line: MCF7; Derived from: pleural effusion. |
|||
MCF-12A |
|||
| ABC-TC0639 | AcceGen | 1 vial | Ask for price |
|
Description: MCF-12A cells exhibit typical luminal epithelial morphology, three dimensional growth in collagen, and form domes in confluent cultures. The cells are positive for epithelial cytokeratins 8, 14 and 18, and negative for cytokeratin 19. |
|||
MCF7 488X1 |
|||
| ABC-TC0644 | AcceGen | 1 vial | Ask for price |
|
Description: Species: human, Caucasian female 69 years old; Tissue: breast; Tumor: adenocarcinoma; Transfected with the exon 5 defective variant of human estrogen receptor cDNA, cloned in pZeoSV vector, resistant to zeocin; Original line: MCF7; Derived from: pleural effusion. |
|||
MCF7 490X1 |
|||
| ABC-TC0645 | AcceGen | 1 vial | Ask for price |
|
Description: Species: human, Caucasian female 69 years old; Tissue: breast; Tumor: adenocarcinoma; Transfected with the exon 4 defective variant of human estrogen receptor cDNA, cloned in pZeoSV vector, resistant to zeocin; Original line: MCF7; Derived from: pleural effusion. |
|||
MCF7 492X1 |
|||
| ABC-TC0646 | AcceGen | 1 vial | Ask for price |
|
Description: Species: human, Caucasian female 69 years old; Tissue: breast; Tumor: adenocarcinoma; Transfected with the pZeoSV-LacZ vector, resistant to zeocin, control for MCF7-488X1 and MCF7-490X1.; Original line: MCF7; Derived from: pleural effusion. |
|||
MCF-10A |
|||
| C0006015 | Addexbio | One Frozen vial | EUR 420 |
MCF-10F |
|||
| C0006039 | Addexbio | One Frozen vial | EUR 500 |
MCF7 [MCF-7] Cells Complete Medium |
|||
| CM-0149 | Elabscience Biotech | 125mL×4 | EUR 108 |
|
Description: Cell lines complete growth medium |
|||
MCF7 [MCF-7] Cells Complete Medium |
|||
| CM-0149-125mL4 | Elabscience Biotech | 125 mL×4 | EUR 108 |
|
Description: Complete Growth Medium |
|||
MCF7 [MCF-7] Cells Complete Medium |
|||
| MBS2568653-4x125mL | MyBiosource | 4x125mL | EUR 160 |
MCF2, CT (MCF2, DBL, Proto-oncogene DBL, Proto-oncogene MCF-2, MCF2-transforming protein, DBL-transforming protein) (AP) |
|||
| MBS6319606-02mL | MyBiosource | 0.2mL | EUR 980 |
MCF2, CT (MCF2, DBL, Proto-oncogene DBL, Proto-oncogene MCF-2, MCF2-transforming protein, DBL-transforming protein) (AP) |
|||
| MBS6319606-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
MCF2, CT (MCF2, DBL, Proto-oncogene DBL, Proto-oncogene MCF-2, MCF2-transforming protein, DBL-transforming protein) (PE) |
|||
| MBS6319616-02mL | MyBiosource | 0.2mL | EUR 980 |
MCF2, CT (MCF2, DBL, Proto-oncogene DBL, Proto-oncogene MCF-2, MCF2-transforming protein, DBL-transforming protein) (PE) |
|||
| MBS6319616-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
MCF2, CT (MCF2, DBL, Proto-oncogene DBL, Proto-oncogene MCF-2, MCF2-transforming protein, DBL-transforming protein) |
|||
| MBS6008662-02mL | MyBiosource | 0.2(mL | EUR 695 |
MCF2, CT (MCF2, DBL, Proto-oncogene DBL, Proto-oncogene MCF-2, MCF2-transforming protein, DBL-transforming protein) |
|||
| MBS6008662-5x02mL | MyBiosource | 5x0.2mL | EUR 2975 |
MCF-10A Cells |
|||
| 116221 | Antibody Research Corporation | 1 Vial | Ask for price |
MCF-10A Cells |
|||
| 116221L | Antibody Research Corporation | 0.5 mg | Ask for price |
MCF-10A Cells |
|||
| 116221R | Antibody Research Corporation | 100 µg | Ask for price |
MCF2, CT (MCF2, DBL, Proto-oncogene DBL, Proto-oncogene MCF-2, MCF2-transforming protein, DBL-transforming protein) (APC) |
|||
| MBS6319607-02mL | MyBiosource | 0.2mL | EUR 980 |
MCF2, CT (MCF2, DBL, Proto-oncogene DBL, Proto-oncogene MCF-2, MCF2-transforming protein, DBL-transforming protein) (APC) |
|||
| MBS6319607-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
MCF2, CT (MCF2, DBL, Proto-oncogene DBL, Proto-oncogene MCF-2, MCF2-transforming protein, DBL-transforming protein) (Biotin) |
|||
| MBS6319608-02mL | MyBiosource | 0.2mL | EUR 980 |
MCF2, CT (MCF2, DBL, Proto-oncogene DBL, Proto-oncogene MCF-2, MCF2-transforming protein, DBL-transforming protein) (Biotin) |
|||
| MBS6319608-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
MCF2, CT (MCF2, DBL, Proto-oncogene DBL, Proto-oncogene MCF-2, MCF2-transforming protein, DBL-transforming protein) (FITC) |
|||
| MBS6319609-02mL | MyBiosource | 0.2mL | EUR 980 |
MCF2, CT (MCF2, DBL, Proto-oncogene DBL, Proto-oncogene MCF-2, MCF2-transforming protein, DBL-transforming protein) (FITC) |
|||
| MBS6319609-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
Lenti ORF particles, Mcf2 (GFP-tagged) - Mouse mcf.2 transforming sequence (Mcf2), 200ul, >10^7 TU/mL |
|||
| MR215353L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Mcf2 (untagged) - Mouse mcf.2 transforming sequence (Mcf2), (10ug) |
|||
| MC222652 | Origene Technologies GmbH | 10 µg | Ask for price |
MCF10-DCIS.com |
|||
| CSC-C7101J | Creative Bioarray | One Frozen vial | Ask for price |
|
Description: Breast Carcinoma Cells |
|||
Mcf2 (GFP-tagged) - Mouse mcf.2 transforming sequence (Mcf2), (10ug) |
|||
| MG215353 | Origene Technologies GmbH | 10 µg | Ask for price |
MCF2 (NM_001171876) Human Over-expression Lysate |
|||
| E45H00313-2 | EnoGene | each | EUR 395 |
MCF2 (NM_001171878) Human Over-expression Lysate |
|||
| E45H00320-2 | EnoGene | each | EUR 395 |
MCF2 (NM_001171876) Human Over-expression Lysate |
|||
| LS004168 | BosterBio | 100ug | EUR 960 |
|
Description: Transient overexpression lysate of MCF.2 cell line derived transforming sequence (MCF2) |
|||
Lenti ORF particles, Mcf2 (Myc-DDK-tagged) - Mouse mcf.2 transforming sequence (Mcf2), 200ul, >10^7 TU/mL |
|||
| MR215353L3V | Origene Technologies GmbH | 200 µl | Ask for price |
Mcf2 (Myc-DDK-tagged) - Mouse mcf.2 transforming sequence (Mcf2) |
|||
| MR215353 | Origene Technologies GmbH | 10 µg | Ask for price |
MCF2, CT (MCF2, DBL, Proto-oncogene DBL, Proto-oncogene MCF-2, MCF2-transforming protein, DBL-transforming protein) (Azide free) (HRP) |
|||
| MBS6319610-02mL | MyBiosource | 0.2mL | EUR 980 |
MCF2, CT (MCF2, DBL, Proto-oncogene DBL, Proto-oncogene MCF-2, MCF2-transforming protein, DBL-transforming protein) (Azide free) (HRP) |
|||
| MBS6319610-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
MCF2, CT (MCF2, DBL, Proto-oncogene DBL, Proto-oncogene MCF-2, MCF2-transforming protein, DBL-transforming protein) (MaxLight 405) |
|||
| MBS6319611-01mL | MyBiosource | 0.1mL | EUR 980 |
MCF2, CT (MCF2, DBL, Proto-oncogene DBL, Proto-oncogene MCF-2, MCF2-transforming protein, DBL-transforming protein) (MaxLight 405) |
|||
| MBS6319611-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
MCF2, CT (MCF2, DBL, Proto-oncogene DBL, Proto-oncogene MCF-2, MCF2-transforming protein, DBL-transforming protein) (MaxLight 490) |
|||
| MBS6319612-01mL | MyBiosource | 0.1mL | EUR 980 |
MCF2, CT (MCF2, DBL, Proto-oncogene DBL, Proto-oncogene MCF-2, MCF2-transforming protein, DBL-transforming protein) (MaxLight 490) |
|||
| MBS6319612-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
MCF2, CT (MCF2, DBL, Proto-oncogene DBL, Proto-oncogene MCF-2, MCF2-transforming protein, DBL-transforming protein) (MaxLight 550) |
|||
| MBS6319613-01mL | MyBiosource | 0.1mL | EUR 980 |
MCF2, CT (MCF2, DBL, Proto-oncogene DBL, Proto-oncogene MCF-2, MCF2-transforming protein, DBL-transforming protein) (MaxLight 550) |
|||
| MBS6319613-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
MCF2, CT (MCF2, DBL, Proto-oncogene DBL, Proto-oncogene MCF-2, MCF2-transforming protein, DBL-transforming protein) (MaxLight 650) |
|||
| MBS6319614-01mL | MyBiosource | 0.1mL | EUR 980 |
MCF2, CT (MCF2, DBL, Proto-oncogene DBL, Proto-oncogene MCF-2, MCF2-transforming protein, DBL-transforming protein) (MaxLight 650) |
|||
| MBS6319614-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
MCF2, CT (MCF2, DBL, Proto-oncogene DBL, Proto-oncogene MCF-2, MCF2-transforming protein, DBL-transforming protein) (MaxLight 750) |
|||
| MBS6319615-01mL | MyBiosource | 0.1mL | EUR 980 |
MCF2, CT (MCF2, DBL, Proto-oncogene DBL, Proto-oncogene MCF-2, MCF2-transforming protein, DBL-transforming protein) (MaxLight 750) |
|||
| MBS6319615-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
MCF7 (MCF-7) Cell Line (Human breast cancer cells) |
|||
| 116018 | Antibody Research Corporation | 1 Vial | Ask for price |
MCF7 (MCF-7) Cell Line (Human breast cancer cells) |
|||
| 116018L | Antibody Research Corporation | 0.5 mg | Ask for price |
MCF7 (MCF-7) Cell Line (Human breast cancer cells) |
|||
| 116018R | Antibody Research Corporation | 100 µg | Ask for price |
Mcf2l (GFP-tagged) - Mouse mcf.2 transforming sequence-like (Mcf2l) |
|||
| MG211735 | Origene Technologies GmbH | 10 µg | Ask for price |
Tamoxifen-resistant MCF-7 (MCF-7/TAM1) Cells |
|||
| T8216 | ABM | 1x10^6 cells / 1.0 ml | EUR 1350 |
Lenti ORF clone of Mcf2 (mGFP-tagged) - Mouse mcf.2 transforming sequence (Mcf2) |
|||
| MR215353L4 | Origene Technologies GmbH | 10 µg | Ask for price |
PKCa Stable Expressing MCF-7 (MCF-7/PKCa20) Cell Line |
|||
| T6115 | ABM | 1x10^6 cells / 1.0 ml | EUR 3950 |
Lenti ORF clone of Mcf2 (Myc-DDK-tagged) - Mouse mcf.2 transforming sequence (Mcf2) |
|||
| MR215353L3 | Origene Technologies GmbH | 10 µg | Ask for price |
Human PTEN (-/-) MCF10A Cell Line |
|||
| ABC-KH12364 | AcceGen | 1 vial | Ask for price |
|
Description: Human PTEN (-/-) MCF10A Cell line is Homozygous knockout of PTEN by deletion of exon 2 resulting in a frameshift |
|||
Human TP53 (-/-) MCF10A Cell Line |
|||
| ABC-KD15933 | AcceGen | 1 vial | Ask for price |
|
Description: Human TP53 (-/-) MCF10A Cell line is Homozygous knockdown of TP53 |
|||
Human TP53 (-/-) MCF10A Cell Line |
|||
| ABC-KH15933 | AcceGen | 1 vial | Ask for price |
|
Description: Human TP53 (-/-) MCF10A Cell line is Homozygous knockout of TP53 |
|||
Human PTEN (-/-) MCF10A Cell Line |
|||
| ABC-KD12364 | AcceGen | 1 vial | Ask for price |
|
Description: Human PTEN (-/-) MCF10A Cell line is Homozygous knockdown of PTEN by deletion of exon 2 resulting in a frameshift |
|||
Mcf2 (untagged) - Mouse mcf.2 transforming sequence (Mcf2), transcript variant 3 |
|||
| MC229197 | Origene Technologies GmbH | 10 µg | Ask for price |
Mcf2 (untagged) - Mouse mcf.2 transforming sequence (Mcf2), transcript variant 1 |
|||
| MC229376 | Origene Technologies GmbH | 10 µg | Ask for price |
Human AKT1 (E17K/+) MCF10A Cell Line |
|||
| ABC-K3003 | AcceGen | 1 vial | Ask for price |
|
Description: Human AKT1 (E17K/+) MCF10A Cell Line is Heterozygous knockin of AKT1 PH domain activating mutation. |
|||
Human RAC1 (Q61L/+) MCF10A Cell Line |
|||
| ABC-KH12606 | AcceGen | 1 vial | Ask for price |
|
Description: Human RAC1 (Q61L/+) MCF10A Cell line is Heterozygous knockin of RAC1 mutant (Q61L). |
|||
Human KRAS (G12V/+) MCF10A Cell Line |
|||
| ABC-KH8079 | AcceGen | 1 vial | Ask for price |
|
Description: Human KRAS (G12V/+) MCF10A Cell line is Heterozygous knockin of KRAS activating mutation (G12V). |
|||
Mcf2l (untagged ORF) - Rat MCF.2 cell line derived transforming sequence-like (Mcf2l), (10 ug) |
|||
| RN208691 | Origene Technologies GmbH | 10 µg | Ask for price |
Human IDH1 (R132H/+) MCF10A Cell Line |
|||
| ABC-KH7140 | AcceGen | 1 vial | Ask for price |
|
Description: Human IDH1 (R132H/+) MCF10A Cell line is Heterozygous knockin of IDH1 dominant-negative (R132H) point mutation. |
|||
Human EGFR (L858R/+) MCF10A Cell Line |
|||
| ABC-KH4647 | AcceGen | 1 vial | Ask for price |
|
Description: Human EGFR (L858R/+) MCF10A Cell line is Heterozygous knockin of EGFR activating mutation (L858R). |
|||
Human EGFR (L861Q/+) MCF10A Cell Line |
|||
| ABC-KH4651 | AcceGen | 1 vial | Ask for price |
|
Description: Human EGFR (L861Q/+) MCF10A Cell line is Heterozygous knockin of EGFR activating mutation (L861Q). |
|||
Human EGFR (T790M/+) MCF10A Cell Line |
|||
| ABC-KH4655 | AcceGen | 1 vial | Ask for price |
|
Description: Human EGFR (T790M/+) MCF10A Cell line is Heterozygous knockin of EGFR mutation (T790M) conferring drug resistance. |
|||
Human BRAF (V600E/+) MCF10A Cell Line |
|||
| ABC-KH1535 | AcceGen | 1 vial | Ask for price |
|
Description: Human BRAF (V600E/+) MCF10A Cell line is Heterozygous knockin of BRAF activating mutation (V600E). |
|||
Human BRAF (V600K/+) MCF10A Cell Line |
|||
| ABC-KH1540 | AcceGen | 1 vial | Ask for price |
|
Description: Human BRAF (V600K/+) MCF10A Cell line is Heterozygous knockin of BRAF activating mutation (V600K). |
|||
Mcf2 (myc-DDK-tagged) - Mouse mcf.2 transforming sequence (Mcf2), transcript variant 1 |
|||
| MR231587 | Origene Technologies GmbH | 10 µg | Ask for price |
Mcf2 (myc-DDK-tagged) - Mouse mcf.2 transforming sequence (Mcf2), transcript variant 3 |
|||
| MR231408 | Origene Technologies GmbH | 10 µg | Ask for price |
MCF2L2 (untagged)-Human MCF.2 cell line derived transforming sequence-like 2 (MCF2L2) |
|||
| SC309977 | Origene Technologies GmbH | 10 µg | Ask for price |
Human TP53 (-/-); KRAS (G12V/+) MCF10A Cell Line |
|||
| ABC-KD15941 | AcceGen | 1 vial | Ask for price |
|
Description: Human TP53 (-/-); KRAS (G12V/+) MCF10A Cell line is Homozygous knockdown of TP53; heterozygous knockin of KRAS activating mutation (G12V) |
|||
Human CTNNB1 (T41A/+/+) MCF10A Cell Line |
|||
| ABC-KH3722 | AcceGen | 1 vial | Ask for price |
|
Description: Human CTNNB1 (T41A/+/+) MCF10A Cell line is Heterozygous knockin of CTNNB1 activating mutation. |
|||
Human TP53 (-/-); KRAS (G12V/+) MCF10A Cell Line |
|||
| ABC-KH15941 | AcceGen | 1 vial | Ask for price |
|
Description: Human TP53 (-/-); KRAS (G12V/+) MCF10A Cell line is Homozygous knockout of TP53; heterozygous knockin of KRAS activating mutation (G12V) |
|||
MCF7 |
|||
| ABC-TC0640 | AcceGen | 1 vial | Ask for price |
|
Description: The MCF7 line retains several characteristics of differentiated mammary epithelium including ability to process oestradiol via cytoplasmic estrogen receptors and the capability of forming domes. The cells express the WNT7B oncogene. |
|||
MCF-7 |
|||
| CSC-C0262 | Creative Bioarray | One Frozen vial | Ask for price |
|
Description: Breast Carcinoma Cells |
|||
MCF-7 |
|||
| MBS201024-01mg | MyBiosource | 0.1mg | EUR 215 |
MCF-7 |
|||
| MBS201024-02mg | MyBiosource | 0.2mg | EUR 230 |
MCF-7 |
|||
| MBS201024-05mg | MyBiosource | 0.5mg | EUR 300 |
MCF-7 |
|||
| MBS201024-5x05mg | MyBiosource | 5x0.5mg | EUR 1115 |
MCF2 |
|||
| MBS8535641-01mL | MyBiosource | 0.1mL | EUR 325 |
MCF2 |
|||
| MBS8535641-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
MCF2 |
|||
| MBS8535641-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
MCF2 |
|||
| MBS8535641-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
MCF2 |
|||
| MBS8535641-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
MCF2L2 (GFP-tagged) - Human MCF.2 cell line derived transforming sequence-like 2 (MCF2L2) |
|||
| RG212640 | Origene Technologies GmbH | 10 µg | Ask for price |